ZX008 Expanded Access Protocol
NCT03780127
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Dravet Syndrome
Interventions
DRUG:
Fenfluramine Hydrochloride
Sponsor
Zogenix, Inc.